Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2020.110153 http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.110153 32763662!7392877!32763662     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Hypotheses 2020 ; 143 (ä): 110153 Nephropedia Template TP {{tp|p=32763662|t=2020. A putative role for the tobacco mosaic virus in smokers resistance to COVID-19 |pdf=|usr=}}{{32763662}} gab.com Text A putative role for the tobacco mosaic virus in smokers resistance to COVID-19 JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32763662 #FOAvip Reports from various countries suggest that tobacco smoking might protect from SARS-CoV-2 infection, since the prevalence of smoking in COVID-19 hospitalized patients is lower than in the respective general population. Apart from nicotine or other chemicals contained in tobacco smoke, we propose that a single-stranded RNA virus that infects tobacco leaves, tobacco mosaic virus (TMV), might be implicated in this effect. TMV, though non-pathogenic, is found in smokers' airways, and stimulates adaptive and innate immunity, with release of specific antibodies and interferons. The latter may have preventive and/or therapeutic effects against COVID-19. If confirmed by epidemiological and interventional studies, this might lead to the use of TMV as an immunological adjuvant against SARS-CoV-2 infection and COVID-19 disease. Twit Text FOAVip A putative role for the tobacco mosaic virus in smokers resistance to COVID-19 ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32763662 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32763662 #FOAvip English Wikipedia <ref>{{Cite pmid|32763662}}</ref> A putative role for the tobacco mosaic virus in smokers resistance to COVID-19 #MMPMID32763662 de Bernardis E; Busa L Med Hypotheses 2020[Oct]; 143 (ä): 110153 PMID32763662show ga Reports from various countries suggest that tobacco smoking might protect from SARS-CoV-2 infection, since the prevalence of smoking in COVID-19 hospitalized patients is lower than in the respective general population. Apart from nicotine or other chemicals contained in tobacco smoke, we propose that a single-stranded RNA virus that infects tobacco leaves, tobacco mosaic virus (TMV), might be implicated in this effect. TMV, though non-pathogenic, is found in smokers' airways, and stimulates adaptive and innate immunity, with release of specific antibodies and interferons. The latter may have preventive and/or therapeutic effects against COVID-19. If confirmed by epidemiological and interventional studies, this might lead to the use of TMV as an immunological adjuvant against SARS-CoV-2 infection and COVID-19 disease. |*Models, Immunological[MESH] |*Pandemics[MESH] |*Smokers[MESH] |*Tobacco Smoking/epidemiology[MESH] |Animals[MESH] |Antibodies, Viral/biosynthesis[MESH] |Betacoronavirus/*immunology[MESH] |COVID-19[MESH] |Coronavirus Infections/epidemiology/*immunology/virology[MESH] |Disease Resistance[MESH] |Humans[MESH] |Interferons/biosynthesis[MESH] |Mice[MESH] |Pneumonia, Viral/epidemiology/*immunology/virology[MESH] |Respiratory System/immunology/virology[MESH] |SARS-CoV-2[MESH] |Tobacco Mosaic Virus/*immunology/isolation & purification[MESH] |Tobacco Products/*virology[MESH]A putative role for the tobacco mosaic virus in smokers resistance to(epmc).pdf DeepDyve Pubget Overpricing